Efficacy and safety of Elagolix in endometriosis: Baseline NRS score subgroup analysis

被引:0
|
作者
Gupta, N. [1 ]
Palve, T. [2 ]
Kamilya, G. [3 ]
Srivastava, S. [4 ]
Ponnuru, M. [5 ]
Bohir, S. [6 ]
Patel, J. [7 ]
Dash, M. [8 ]
Saigal, S. [9 ]
Savalia, K. [10 ]
Gupta, T. [11 ]
Chaudhary, D. [12 ]
Rangaswamy, M. [13 ]
Shah, P. [14 ]
Bhat, V. V. [15 ]
Shetty, A. [16 ]
Saha, S. [16 ]
Quadros, R. [16 ]
Patil, D. [16 ]
Patel, P. [16 ]
Ghadge, P. [16 ]
Mane, A. [16 ]
Mehta, S. [16 ]
机构
[1] GSVM Med Coll, Kanpur, Uttar Pradesh, India
[2] Cama & Albless Hosp, Mumbai, Maharashtra, India
[3] IPGME&R & SSKM Hosp, Kolkata, India
[4] Om Surg Ctr & Matern Home, Varanasi, Uttar Pradesh, India
[5] Modern Govt Matern Hosp, Hyderabad, Telangana, India
[6] KKasturi Medicare Pvt Ltd, Thana, India
[7] Pagarav Hosp & ICU, Gandhinagar, India
[8] Sparsh Hosp & Crit Care Pvt Ltd, Bhubaneswar, India
[9] Brij Med Ctr Pvt Ltd, Kanpur, Uttar Pradesh, India
[10] Priyadarshani Nursing Home, Virar E, India
[11] Udyan Hlth Care Pvt Ltd, Lucknow, Uttar Pradesh, India
[12] SMS Hosp, Jaipur, Rajasthan, India
[13] Mandya Inst Med Sci, Mandya, India
[14] SVP Hosp, Ahmadabad, Gujarat, India
[15] Radhakrishna Multispecial Hosp & IVF Ctr, Bangalore, Karnataka, India
[16] Sun Pharma Labs Ltd, Mumbai, Maharashtra, India
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
eP- 069
引用
收藏
页码:75 / 76
页数:2
相关论文
共 50 条
  • [1] Efficacy and safety of elagolix in endometriosis: Disease duration subgroup analysis
    Gupta, N.
    Palve, T.
    Kamilya, G.
    Srivastava, S.
    Malathi, P.
    Bohir, S.
    Patel, J. S.
    Dash, M. K.
    Saigal, S.
    Savalia, K. P.
    Gupta, T.
    Chaudhary, D.
    Manohar, R.
    Shah, P.
    Bhat, V. V.
    Shetty, A.
    Saha, S.
    Quadros, R.
    Patil, D.
    Patel, P.
    Ghadge, P.
    Mane, A.
    Mehta, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 77 - 78
  • [2] Efficacy of elagolix in the treatment of endometriosis
    Perricos, Alexandra
    Wenzl, Rene
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (13) : 1391 - 1397
  • [3] Long-Term Safety and Efficacy of Elagolix Treatment in Women With Endometriosis-Associated Pain
    Surrey, Eric
    Taylor, Hugh S.
    Duan, W. Rachel
    Peloso, Paul
    Schwefel, Brittany
    Chwalisz, Kristof
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 4S - 4S
  • [4] EFFICACY AND SAFETY OF ELAGOLIX IN A SUBGROUP OF WOMEN WITH UTERINE FIBROIDS AND ADENOMYOSIS: RESULTS FROM A PHASE 2 TRIAL
    Taylor, H. S.
    Bedaiwy, M. A.
    Lukes, A. S.
    Chwalisz, K.
    Owens, C.
    Bradley, L.
    FERTILITY AND STERILITY, 2018, 110 (04) : E61 - E61
  • [5] The short- and mid-term efficacy and safety of elagolix in the management of pain associated with endometriosis: A systematic review and meta-analysis
    Zhang, Yue
    Wei, Wei
    Chang, En
    Leng, Yan-en
    Hou, Yi
    Wei, Xi
    Yue, Xin
    Zhong, Li
    Liu, Jin-feng
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2024, 53 (09)
  • [6] Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis
    Kushner, Robert F.
    Fink-Jensen, Anders
    Frenkel, Ofir
    McGowan, Barbara
    Goldman, Bryan
    Overvad, Maria
    Wadden, Thomas
    OBESITY, 2024, 32 (02) : 273 - 280
  • [7] Elagolix Exposure-Efficacy Analysis
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (04) : 691 - 691
  • [8] Efficacy and safety of Elagolix in endometriosis: Phase-III randomized double-blind active-controlled trial
    Gupta, N.
    Palve, T.
    Kamilya, G.
    Srivastava, S.
    Malathi, P.
    Bohir, S.
    Patel, J. S.
    Dash, M. K.
    Saigal, S.
    Savalia, K. P.
    Gupta, T.
    Chaudhary, D.
    Manohar, R.
    Shah, P.
    Bhat, V. V.
    Shetty, A.
    Saha, S.
    Quadros, R.
    Patil, D.
    Patel, P.
    Ghadge, P.
    Mane, A.
    Mehta, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 3 - 3
  • [9] Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN)
    Yoo, Albert J.
    Berkhemer, Olvert A.
    Fransen, Puck S. S.
    van den Berg, Lucie A.
    Beumer, Debbie
    Lingsma, Hester F.
    Schonewille, Wouter J.
    Sprengers, Marieke E. S.
    van den Berg, Rene
    van Walderveen, Marianne A. A.
    Beenen, Ludo F. M.
    Wermer, Marieke J. H.
    Nijeholt, Geert J. Lycklama A.
    Boiten, Jelis
    Jenniskens, Sjoerd F. M.
    Bot, Joseph C. J.
    Boers, Anna M. M.
    Marquering, Henk A.
    Roos, Yvo B. W. E. M.
    van Oostenbrugge, Robert J.
    Dippel, Diederik W. J.
    van der Lugt, Aad
    van Zwam, Wim H.
    Majoie, Charles B. L. M.
    LANCET NEUROLOGY, 2016, 15 (07): : 685 - 694
  • [10] Baseline Burden of Endometriosis-Associated Pain among Women in Two Phase 3 Elagolix Studies
    Leyland, Nicholas
    Surrey, Eric
    Soliman, Ahmed M.
    Eichner, Samantha
    Chen, Kun
    Snabes, Michael
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 186S - 187S